Abstract:Peripherin/rds (p/rds), an integral membrane protein from the transmembrane 4 (TMF4) superfamily, possesses a multi-functional C-terminal domain that plays crucial roles in rod outer segment (ROS) disk renewal and structure. Here, we report that the calcium binding protein calmodulin (CaM) binds to the C-terminal domain of p/rds. Fluorescence spectroscopy reveals Ca 2+ -dependent association of CaM with a polypeptide corresponding to the C-terminal domain of p/rds. The fluorescence anisotropy of the polypeptid… Show more
“…When MREG was added to PRPH2/RDS membrane fusion assays, the rate of membrane fusion was significantly reduced, suggesting that MREG acts as an inhibitor of PRPH2/RDS’ fusogenic activity (Boesze-Battaglia et al, 2007a). The C-terminus can also associate with the calcium binding protein calmodulin in a Ca 2+ dependent manner (Edrington et al, 2007b). Similarly to MREG, this binding seems to inhibit the fusion capacity of the PRPH2/RDS protein and binds to a similar region of the protein (Edrington et al, 2007b).…”
Section: Role Of Prph2/rds In the Photoreceptormentioning
confidence: 99%
“…The C-terminus can also associate with the calcium binding protein calmodulin in a Ca 2+ dependent manner (Edrington et al, 2007b). Similarly to MREG, this binding seems to inhibit the fusion capacity of the PRPH2/RDS protein and binds to a similar region of the protein (Edrington et al, 2007b). The mechanisms of PRPH2/RDS fusogenic activity and its role in OS biogenesis is not fully elucidated, it is clear that PRPH2/RDS fusogenic activity involves the PRPH2/RDS C-terminus and can be regulated by various binding partners.…”
Section: Role Of Prph2/rds In the Photoreceptormentioning
Peripherin2 (PRPH2), also known as RDS (retinal degeneration slow) is a photoreceptor specific glycoprotein which is essential for normal photoreceptor health and vision. PRPH2/RDS is necessary for the proper formation of both rod and cone photoreceptor outer segments, the organelle specialized for visual transduction. When PRPH2/RDS is defective or absent, outer segments become disorganized or fail to form entirely and the photoreceptors subsequently degenerate. Multiple PRPH2/RDS disease-causing mutations have been found in humans, and they are associated with various blinding diseases of the retina such as macular degeneration and retinitis pigmentosa, the vast majority of which are inherited dominantly, though recessive LCA and digenic RP have also been associated with RDS mutations. Since its initial discovery, the scientific community has dedicated a considerable amount of effort to understanding the molecular function and disease mechanisms of PRPH2/RDS. This work has led to an understanding of how the PRPH2/RDS molecule assembles into complexes and functions as a necessary part of the machinery that forms new outer segment discs, as well as leading to fundamental discoveries about the mechanisms that underlie OS biogenesis. Here we discuss PRPH2/RDS-associated research and how experimental results have driven the understanding of the PRPH2/RDS protein and its role in human disease.
“…When MREG was added to PRPH2/RDS membrane fusion assays, the rate of membrane fusion was significantly reduced, suggesting that MREG acts as an inhibitor of PRPH2/RDS’ fusogenic activity (Boesze-Battaglia et al, 2007a). The C-terminus can also associate with the calcium binding protein calmodulin in a Ca 2+ dependent manner (Edrington et al, 2007b). Similarly to MREG, this binding seems to inhibit the fusion capacity of the PRPH2/RDS protein and binds to a similar region of the protein (Edrington et al, 2007b).…”
Section: Role Of Prph2/rds In the Photoreceptormentioning
confidence: 99%
“…The C-terminus can also associate with the calcium binding protein calmodulin in a Ca 2+ dependent manner (Edrington et al, 2007b). Similarly to MREG, this binding seems to inhibit the fusion capacity of the PRPH2/RDS protein and binds to a similar region of the protein (Edrington et al, 2007b). The mechanisms of PRPH2/RDS fusogenic activity and its role in OS biogenesis is not fully elucidated, it is clear that PRPH2/RDS fusogenic activity involves the PRPH2/RDS C-terminus and can be regulated by various binding partners.…”
Section: Role Of Prph2/rds In the Photoreceptormentioning
Peripherin2 (PRPH2), also known as RDS (retinal degeneration slow) is a photoreceptor specific glycoprotein which is essential for normal photoreceptor health and vision. PRPH2/RDS is necessary for the proper formation of both rod and cone photoreceptor outer segments, the organelle specialized for visual transduction. When PRPH2/RDS is defective or absent, outer segments become disorganized or fail to form entirely and the photoreceptors subsequently degenerate. Multiple PRPH2/RDS disease-causing mutations have been found in humans, and they are associated with various blinding diseases of the retina such as macular degeneration and retinitis pigmentosa, the vast majority of which are inherited dominantly, though recessive LCA and digenic RP have also been associated with RDS mutations. Since its initial discovery, the scientific community has dedicated a considerable amount of effort to understanding the molecular function and disease mechanisms of PRPH2/RDS. This work has led to an understanding of how the PRPH2/RDS molecule assembles into complexes and functions as a necessary part of the machinery that forms new outer segment discs, as well as leading to fundamental discoveries about the mechanisms that underlie OS biogenesis. Here we discuss PRPH2/RDS-associated research and how experimental results have driven the understanding of the PRPH2/RDS protein and its role in human disease.
“…CaM binds RDS in a calcium-dependent manner [49]. The putative CaM binding site is predicted to be between residues E314 and G329, roughly corresponding to the membrane fusion domain of the RDS C-terminus.…”
Section: Structure and Complex Assemblymentioning
confidence: 99%
“…The putative CaM binding site is predicted to be between residues E314 and G329, roughly corresponding to the membrane fusion domain of the RDS C-terminus. It has been proposed that this binding plays a role in the apical shedding of the rod OS by regulating the fusogenic properties of the RDS C-terminus [49]. MREG and CaM binding data suggest that RDS-mediated membrane fusion is differently regulated based on subcellular localization of the interacting partners and cellular conditions.…”
The two primary photoreceptor-specific tetraspanins are retinal degeneration slow (RDS) and rod outer segment membrane protein-1 (ROM-1). These proteins associate together to form different complexes necessary for the proper structure of the photoreceptor outer segment rim region. Mutations in RDS cause blinding retinal degenerative disease in both rods and cones by mechanisms that remain unknown. Tetraspanins are implicated in a variety of cellular processes and exert their function via the formation of tetraspanin-enriched microdomains. This review focuses on correlations between RDS and other members of the tetraspanin superfamily, particularly emphasizing protein structure, complex assembly, and post-translational modifications, with the goal of furthering our understanding of the structural and functional role of RDS and ROM-1 in outer segment morphogenesis and maintenance, and our understanding of the pathogenesis associated with RDS and ROM-1 mutations.
“…As the peripherin/rds protein traffics up the transition zone to aid in the formation of new disks it has numerous binding partners, including a cargo sorting protein melanoregulin (MREG) as well as Calcium/Calmodulin (Ca/CaM) (Boesze-Battaglia, 2007; Edrington, 2007a). These functional and binding regions of peripherin/rds are illustrated in Fig.1.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.